用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
AVENTIS PHARMA SA [FR](14)
SCINOPHARM TAIWAN LTD [TW](5)
SANOFI AVENTIS(4)
CHONGQING TAIHAO PHARMACEUTICAL CO LTD(4)
FRESENIUS KABI ONCOLOGY LTD [IN](4)
SCINOPHARM TAIWAN LTD(3)
JIANGSU AOSAIKANG PHARM CO LTD(3)
UNIV FUDAN(3)
Sanofi(3)
VRASPIR PAVEL [CZ](3)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Cabazitaxel'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
4
5
6
下页
尾页
共
95
条记录, 当前第1/10页。
公开号
公开日
申请号
申请日
1.
AU2012306057A1
2014/3/20
AU20120306057
2012/9/7
专利标题
:Crystalline forms of cabazitaxel
专利权人
:
SCINOPHARM TAIWAN LTD
;
, The present invention provides crystalline forms, including an anhydrate form, of cabazitaxel and processes for the preparation of these forms, designated as Forms C1, C2, C3, C4, C5, C6, C7, C8, C8b, C9 and C9p.
2.
US2014058119A1
2014/2/27
US201213625155
2012/9/24
专利标题
:PROCESS FOR THE PREPARATION CABAZITAXEL
专利权人
:
FRESENIUS KABI ONCOLOGY LTD [IN]
;
The present invention discloses a process for the preparation of 4-acetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1-hydroxy-7beta,10beta-dimethoxy-9-oxotax-11-en-13alpha-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate Cabazitaxel (I).
3.
US20140056996A1
2014/2/27
专利标题
:Antitumoral combination comprising cabazitaxel and cisplatin
专利权人
:
Aventis Pharma S.a.
;
The present invention relates to a combination comprising cabazitaxel and cisplatin. The present invention relates also to a pharmaceutical composition containing such a combination and to a pharmaceutical kit comprising: (i) a first galenic formulation comprising cabazitaxel; and (ii) a second galenic formulation comprising cisplatin. The invention relates also to the use of this combination and/or pharmaceutical composition and/or pharmaceutical kit in the treatment of neoplastic diseases more...
4.
WO2014028704A1
2014/2/20
WO2013US55083
2013/8/15
专利标题
:STABLE PHARMACEUTICAL FORMULATION OF CABAZITAXEL
专利权人
:
YUNG SHIN PHARM IND CO LTD
;
CARLSBAD TECHNOLOGY INC [US]
;
The present invention relates to a stable liquid cabazitaxel formulation in an enclosed container. The enclosed container comprises a liquid phase and an gaseous phase, wherein the liquid phase comprises cabazitaxel, polysorbate 80, ethanol, and one or more pH adjusters to maintain pH about 2.8-6.0, and the gaseous phase is saturated with CO2. The present invention is also directed to a process for preparing the enclosed liquid pharmaceutical composition container.
5.
US2014045926A1
2014/2/13
US201313965015
2013/8/12
专利标题
:CRYSTALLINE FORMS OF CABAZITAXEL
专利权人
:
SCINOPHARM TAIWAN LTD [TW]
;
The present invention provides crystalline forms, including an anhydrate form, of cabazitaxel and processes for the preparation of these forms, designated as Forms C1, C2, C3, C4, C5, C6, C7, C8, C8b, C9 and C9p.
6.
KR20140018917A
2014/2/13
KR20137026851
2012/4/11
专利标题
:SOLID STATE FORMS OF CABAZITAXEL AND PROCESSES FOR PREPARATION THEREOF
专利权人
:
PLUS CHEMICALS S A [CH]
;
7.
WO2014022237A1
2014/2/6
WO2013US52366
2013/7/26
专利标题
:AMORPHOUS CABAZITAXEL
专利权人
:
YUNG SHIN PHARM IND CO LTD
;
The present invention is directed to an amorphous form of cabazitaxel, which can be prepared by dissolving a solid form of cabazitaxel in an organic solvent, and removing the organic solvent to dryness. The amorphous form of cabazitaxel is characterized by DSC as in FIG. 1 and/or X-ray powder diffraction pattern as in FIG. 2.
8.
WO2014015760A1
2014/1/30
WO2013CN79575
2013/7/18
专利标题
:CRYSTAL FORM OF CABAZITAXEL AND PREPARATION METHOD THEREOF
专利权人
:
CHONGQING TAIHAO PHARMACEUTICAL CO LTD [CN]
;
The present invention relates to the field of medical chemistry, and discloses a preparation method for three crystal forms of cabazitaxel, that is, ester compound crystalline form J of cabazitaxel, hydrate crystalline form G of cabazitaxel and crystalline form I of cabazitaxel, and a novel crystalline form of cabazitaxel. The novel crystalline form of cabazitaxel according to the invention has good stability and good solubility in commonly used solvents, and is easy to be preserved and is stabl...
9.
WO2014015422A1
2014/1/30
WO2013CA00674
2013/7/26
专利标题
:CELLULOSE-BASED NANOPARTICLES FOR DRUG DELIVERY
专利权人
:
ONTARIO INST FOR CANCER RES [CA]
;
Compounds comprising acetylated carboxymethylcellulose covalently linked to at least one poly( ethylene glycol) and at least one hydrophobic drug comprising taxane have shown to have utility in the preparation of self-assembling nanoparticles. Said nanoparticles exhibit activity in the treatment of cancers including breast, lung, pancreatic and metastatic cancers. Said taxane may be any taxane including cabazitaxel and larotaxel.
10.
EP2688877A1
2014/1/29
EP20120716918
2012/4/11
专利标题
:SOLID STATE FORMS OF CABAZITAXEL AND PROCESSES FOR PREPARATION THEREOF
专利权人
:
PLUS CHEMICALS SA [CH]
;
首页
1
2
3
4
5
6
下页
尾页
共
95
条记录, 当前第1/10页。
当前查询条件: [药品] 包含 'Cabazitaxel'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文